UnitedHealth declined to comment on Gottlieb’s appointment, which comes as the company works to improve its relationship with ...
Top Trump administration officials have taken issue with Marty Makary’s management style, pointing to infighting between his ...
Former Food and Drug Administration Commissioner Scott Gottlieb, M.D., is joining the board at industry giant UnitedHealth ...
UnitedHealth Group said on Tuesday it had named former U.S. Food and Drug Administration commissioner Scott Gottlieb to its ...
HHS Secretary RFK Jr. allegedly considered limiting the role of FDA Commissioner Marty Makary and assigning another official ...
Health Secretary Robert Kennedy Jr. considered installing a new leader to manage the agency on a day-to-day basis.
The first wave of Commissioner’s National Priority Vouchers signals a fundamental shift in FDA competitiveness, rewarding companies that pair breakthrough science with affordability commitments, ...
Hormone therapy drugs have carried box warning labels for years. Food and Drug Administration Commissioner Marty Makary talks ...
In the past, biosimilar makers have been able to invalidate some of those patents through a sped-up process called “inter ...
The FDA’s new Commissioner’s National Priority Voucher signals a transformative shift in U.S. drug review, tying accelerated approval to manufacturing readiness, domestic supply-chain strength, and ...
Priority voucher awardees and regulators could feel pressure to “meet the moment” as FDA watchers question the intent and ...
Gottlieb, who had served as the FDA chief from 2017 to 2019, stepped down abruptly in 2019 and joined the board of U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback